throbber
Downloaded from https://academic.oup.com/ajcn/article-abstract/50/6/1401/4695064 by barrettrabinow@gmail.com on 16 May 2020
`
`Hypercysteinemia
`after
`oral
`cysteine
`
`delayed
`and
`loads13
`
`sulfur
`
`excretion
`
`in cirrhotics
`
`Diane
`
`L Tribble,
`
`Dean
`
`P Jones,
`
`Abbas
`
`Ardehali,
`
`Ruth M Feeley,
`
`and DanielRudman
`
`via
`
`transsulfuration
`hepatic
`the
`methionine
`from
`cysteine
`of
`Biosynthesis
`ABSTRACt’
`cysteine
`in the
`require
`might
`who
`therefore
`patients,
`cirrhotic
`in some
`is impaired
`pathway
`in the
`liver,
`the
`occurs
`primarily
`of cysteine
`also
`metabolism
`further
`diet.
`However,
`because
`administered
`oral
`in cirrhosis.
`We
`be
`impaired
`could
`acid
`this
`amino
`metabolic
`clearance
`of
`cyst(e)ine
`and
`healthy
`volunteers.
`Plasma
`and
`(free
`patients
`loads
`of L-cysteine
`to cirrhotic
`#{189}cystine)
`protein-bound
`cysteine,
`and
`urinary
`sulfur-containing
`constituents
`mea-
`and
`were
`subjects
`exhibited
`a greater
`maximal
`cyst(e)-
`plasma
`Cirrhotic
`sured
`at various
`times
`postload.
`half-life
`(t#{189})and
`a delayed
`excretion
`of metabolic
`elimination
`inc
`concentration
`and
`plasma
`was
`The
`postload
`increase
`in total
`plasma
`cyst(e)ine
`end
`products
`an oral L-cysteine
`load.
`after
`accounted
`for primarily
`by an increase
`in the
`disulfide
`form (cystine).
`These
`studies
`show that
`Am J Cliii Nutr
`ability
`clear
`cyst(e)ine
`from
`the
`plasma.
`cirrhotics
`have
`an
`impaired
`1989;50:
`1401-6.
`
`to
`
`KEY WORDS
`
`Hypercysteinemia,
`
`sulfur,
`
`cirrhosis
`
`omis-
`that
`established
`al
`by Rose
`studies
`Early
`of healthy
`diet
`from
`the
`acids
`amino
`any
`ofeight
`sion
`of
`nitrogen
`bal-
`negative
`in a reversible
`adult
`males
`resulted
`that
`humans
`are
`un-
`studies
`showed
`ance.
`Subsequent
`novo.
`With
`the
`de
`acids
`these
`amino
`able
`synthesize
`parenteral
`nu-
`and
`enteral
`defined
`advent
`of chemically
`ofbetter
`cri-
`development
`and
`tritional
`formulations
`nutriture,
`other
`protein
`individual
`teria
`defining
`for
`nonessential
`have
`as
`amino
`acids
`originally
`classified
`in certain
`clinical
`condi-
`been
`found
`to be
`indispensible
`tions
`and
`referred
`to as conditionally
`essential
`(2) or
`are
`(3).
`acquired
`indispensable
`amino
`acids
`biosynthe-
`cysteine
`Methionine
`utilization,
`and
`hence
`of
`these
`are
`impaired
`in
`cirrhotics
`(4). A subset
`sis,
`became
`hypocysteinemic
`when
`maintained
`tients
`cysteine-free
`total
`parenteral
`nutrition
`(TPN)
`tions
`and
`showed
`signs
`ofdeteriorating
`nutritional
`despite
`provision
`of
`excess
`calories
`and
`repletion
`the
`protein
`N (5).
`Simultaneous
`declines
`have
`been
`noted
`the
`concentrations
`ofa-aminobutync
`acid,
`taurine,
`compounds
`glutathione
`plasma,
`three
`derived
`several
`cysteine
`Improvement
`nutritional
`(6).
`can
`be
`ables
`a positive
`N balance
`attained
`and
`wk
`cysteine
`(cystine)
`supplementation
`(5).
`ingly,
`a source
`ofcysteine
`has
`been
`suggested
`as
`sary
`component
`ofthe
`cirrhotic
`diet
`(2-5).
`most
`Because
`currently
`available
`elemental
`tional
`formulas
`either
`or
`contain
`only
`
`of
`
`and/
`revision
`formula
`cystine),
`(as
`cysteine
`amounts
`mix-
`these
`providing
`when
`supplementation
`or
`cysteine
`However,
`indicated.
`may
`be
`cirrhotic
`patients
`tures
`to
`there-
`by hepatic
`enzymes;
`is degraded
`primarily
`cysteine
`cirrhotic
`processing
`by
`the
`disorders
`cysteine
`in
`fore,
`Elevated
`plasma
`cys-
`could
`cause
`hypercysteinemia.
`liver
`patients
`consuming
`was
`noted
`in
`some
`cirrhotic
`teine
`on the
`relative
`amounts
`foods
`(2) and,
`depending
`mixed
`in the
`plasma,
`could
`con-
`various
`forms
`ofcysteine
`ofthe
`complications
`including
`to
`additional
`medical
`tribute
`function
`ofplasma
`proteins
`alterations
`in the
`widespread
`thiol
`and
`disulfide
`status
`groups.
`thiol
`The
`with
`critical
`patients
`in
`favor
`of
`the
`in
`is altered
`cirrhotic
`of
`cysteine
`forms
`[cystine,
`cysteine-mixed
`disulfides,
`and
`disulfide
`cysteine
`(6)].
`Problems
`also
`could
`arise
`protein-bound
`build-up
`offree
`and
`protein-bound
`ho-
`from
`a secondary
`mocysteine,
`a transsulfuration
`intermediate
`proximal
`to
`cysteine.
`metabolite
`been
`implicated
`in causing
`This
`damage
`to proteins
`and
`vascular
`endothelium
`and
`other
`tissues
`(7).
`
`has
`to the
`
`of Nutrition,
`and Division
`of Biochemistry
`(cid:1) From the Department
`School
`of Medi-
`Department
`University
`Health,
`Emory
`ofCommunity
`cine, Atlanta,
`and
`the Department
`ofMedicine,
`University
`of Califor-
`San Francisco.
`nia,
`2 Supported
`by NIH grant
`3 Address
`reprint
`requests
`Medical
`College
`ofWisconsin,
`ReceivedMarch
`15, 1988.
`Accepted
`for publication
`
`RR 39.
`to D Rudman,
`Milwaukee,
`
`Department
`WI 53226.
`
`of Medicine,
`
`December
`
`14, 1988.
`
`pa-
`on
`
`formula-
`status
`
`of
`in
`and
`from
`van-
`within
`Accord-
`a neces-
`
`1
`
`nutri-
`minor
`
`Introduction
`
`to
`
`in
`
`of
`
`et
`
`(1)
`
`the
`
`in
`
`lack
`
`Am J C/in Nuir
`
`1989;50:
`
`1401-6.
`
`Printed
`
`in USA. © 1989 American
`
`Society
`
`for Clinical
`
`Nutrition
`
`1401
`
`Eton Ex. 1040
`1 of 6
`
`

`

`1402
`
`TABLE
`Clinical
`cirrhosis
`
`1
`data
`
`ofthe
`
`four
`
`patients
`
`with
`
`biopsy-proven
`
`micronodular
`
`TRIBBLE
`
`ET AL
`
`consecutive
`Six
`tion.
`Blood
`samples
`load.
`ofthe
`load
`tration
`ofplasma
`analysis
`the
`During
`tests,
`cirrhotic
`ical
`encephalopathy.
`motor
`skills were
`
`course
`subjects
`
`1
`
`2
`
`3
`
`4
`
`50
`F
`
`3
`Yes
`
`No
`98
`0.5 1
`27
`27
`
`41
`M
`4
`Yes
`
`No
`93
`0.54
`31
`2 1
`
`61
`M
`
`6
`Yes
`
`Yes
`110
`0.63
`20
`2 1
`
`55
`M
`
`8
`Yes
`
`Yes
`106
`0.59
`15
`34
`
`(y)
`
`diagnosis
`initial
`since
`ofencephalopathy
`ofbleeding
`esophageal
`
`Age(y)
`Sex
`Time
`History
`History
`varices
`Bodyweight(%idealbodywt)
`Serum albumin
`(mmol/L)5
`Serum
`bilirubin
`(zmol/L)5
`Blood NH3 (jzmol/L)5
`
`S Fasting
`
`venous
`
`blood.
`
`The
`ofcirrhotic
`
`ofthis
`purpose
`patients
`
`study
`to oral
`
`was
`loads
`
`to examine
`of L-cysteine.
`
`the
`
`response
`
`Experimental
`
`design
`
`and
`
`implementation
`
`Subjects
`
`and
`patients
`cirrhotic
`offour
`consisted
`population
`study
`The
`group
`cirrhotic
`1 y. The
`42-6
`subjects
`aged
`control
`healthy
`five
`biopsy-
`with
`male
`adults
`female
`and
`three
`one
`comprised
`physical
`by
`cirrhosis
`who,
`micronodular
`(alcoholic)
`proven,
`of hepa-
`show any
`evidence
`not
`and
`laboratory
`assessment,
`did
`dis-
`varices,
`ascites,
`hepatorenal
`titis,
`encephalopathy,
`bleeding
`for
`had
`abstained
`from alcohol
`ease,
`or diabetes
`mellitus.
`They
`had
`and
`3 mo
`according
`to
`history
`from
`patient
`family.
`All
`being
`a history
`of hepatic
`encephalopathy
`and were
`therefore
`are
`diet.
`treated
`with
`a protein-restricted
`Their
`clinical
`features
`control
`summarized
`in Table
`1 . The
`group
`consisted
`of one
`adult
`female
`and
`four
`adult male
`volunteers
`aged
`24-36
`y with
`no history
`of hepatobiliary
`disease.
`Results
`ofall
`conventional
`liver
`tests
`(serum
`bilirubin,
`alkaline
`phosphatase,
`glutamate
`and
`oxaloacetate
`aminotransferase,
`lactate
`dehydrogenase,
`all control
`prothrombin
`time)
`were
`within
`normal
`range
`for
`the
`subjects.
`investigation
`was
`conducted
`with
`approval
`of
`the
`The
`Emory
`University
`Human
`Investigations
`Committee
`and with
`the
`informed
`consent
`ofall
`subjects.
`
`Experimental
`
`procedures
`
`containing
`for weight
`mainte-
`equation,
`
`for 5 d on
`equilibrated
`were
`All participants
`a diet
`calories
`adequate
`2 g Na(cid:1)
`with
`g protein
`and
`40
`required
`for weight
`caloric
`intake
`maintenance.
`The
`Harris
`and
`Benedict
`by
`the
`nance
`was
`calculated
`and
`age (8).
`weight,
`which
`adjusts
`for height,
`beginning
`urine
`samples
`were
`collected
`Six consecutive
`6-h
`of S-con-
`for
`analysis
`ofbasal
`excretion
`4th
`at 0800
`on
`the
`day
`commencing
`At 0800
`on the 6th day
`after
`taming
`constituents.
`diet,
`(40.6
`mg/kg
`the
`40-g-protein
`an
`oral
`bolus
`of L-cysteine
`was
`weight)
`given
`in
`150 mL of carbohydrate-free
`ideal
`body
`of
`same
`vehicle.
`The
`concentration
`the
`cysteine
`load
`was
`the
`load
`as
`that
`of
`the methionine
`(50 mg/kg
`ideal
`body
`weight)
`Emory
`previously
`utilized
`at
`the
`Clinical
`Research
`Center
`(4).
`Breakfast,
`lunch,
`and
`dinner
`were
`delivered
`at 0.5,
`4, and
`9 h
`postload,
`respectively.
`Subjects
`were
`instructed
`urine
`collections
`began
`
`void
`to
`immediately
`
`h before
`0.5
`after
`cysteine
`
`the
`
`load;
`oral
`administra-
`
`samples
`urine
`6-h
`immediately
`drawn
`were
`times
`postload
`at various
`and
`concentrations.
`acid
`amino
`study
`and
`particularly
`ofthe
`carefully
`observed
`were
`No
`significant
`changes
`in any
`ofthe
`cirrhotic
`
`were
`
`collected
`before
`(up
`
`post-
`adminis-
`to 8 h)
`
`for
`
`after
`signs
`for
`orientation
`in
`patients.
`
`load
`the
`of din-
`
`or
`
`noted
`
`Downloaded from https://academic.oup.com/ajcn/article-abstract/50/6/1401/4695064 by barrettrabinow@gmail.com on 16 May 2020
`
`Analytical
`
`procedures
`
`concentrations.
`acid
`amino
`ofplasma
`Determination
`into
`heparinized
`tubes.
`drawn
`samples
`were
`lO-mL
`blood
`treated
`with
`iodoacetic
`acid
`was
`immediately
`blood
`sample
`mL of a 500 mg/mL
`to
`prevent
`rapid
`autooxidation
`solution)
`Both
`S-carboxymethyl
`derivative.
`of cysteine
`by
`forming
`the
`were
`Samples
`10 mm to pellet
`the
`cells.
`samples
`centrifuged
`for
`ofthe
`#{176}Cuntil
`filtered
`and
`frozen
`-80
`(1 .5 mL)
`plasma
`were
`at
`Plasma
`analysis.
`samples
`were
`maintained
`at
`#{176}Cfor
`-80
`analysis.
`wk before
`Under
`these
`conditions
`the
`plasma
`amino
`acid
`concentrations
`are
`stable
`for
`8 mo
`(5).
`an amino
`Plasma
`aminograms
`were measured
`with
`Palo Alto,
`alyzer
`(Model
`121,
`Beckman
`Instruments,
`Plasma
`cysteine
`concentrations
`(as
`the S-carboxymethyl
`(9).
`al
`ative)
`were
`measured
`by
`the method
`of Brigham
`et
`tein-bound
`cysteine
`was
`determined
`by the
`spectrophotometric
`ofMalloy
`et al
`(10)
`and Gaitonde
`(1 1).
`method
`creati-
`and
`Analysis
`ofurinary
`sulfur-containing
`compounds
`frozen
`nine. Two
`lO-mL samples
`ofeach
`6-h urine
`sample were
`the
`at
`-80
`#{176}Cfor
`later
`analysis
`ofamino
`acids
`and
`taurine
`(5);
`remainder
`were
`stored
`for
`later
`analysis
`of S and
`creatinine.
`Inorganic
`S (H2S
`and
`SO42)
`was measured
`by the method
`(12). Urinary
`used
`Folin
`creatinine
`values
`were
`to
`correct
`on
`inaccurate
`urine
`collections.
`Creatinine
`was measured
`automated
`Technicon
`analyzer
`in a manner
`similar
`to that
`scribed
`by Chasson
`al
`(13).
`
`Two
`One
`(0.1
`
`6
`
`an-
`acid
`CA)
`(5).
`deriv-
`Pro-
`
`of
`for
`an
`de-
`
`et
`
`Pharmacokinetic
`
`evaluation
`
`and
`
`statistical
`
`analyses
`
`(Ks)
`
`of distri-
`and
`the
`line
`on
`vs
`
`volume
`and
`from the
`slope
`regression
`concentration
`acid
`calculated
`by multiply-
`(t#{189})was
`determined
`
`of elimination
`constant
`rate
`The
`were
`determined
`ofcysteine
`(Vd)
`bution
`of
`the
`least-squares
`respectively,
`y intercept,
`of plasma
`amino
`a semilogarithmic
`plot
`time.
`The metabolic
`clearance
`rate was
`K(cid:1)
`ing
`by Vd.
`The
`elimination
`half-life
`from tY2 = 0.693/Kr.
`The
`two-group
`evaluate
`group
`centrations
`and
`were
`compared
`ance
`(14).
`
`test
`t
`differences
`urinary
`by using
`
`or Mann-Whitney
`in
`basal
`plasma
`S excretion.
`Postload
`a repeated
`measures
`
`to
`used
`U test was
`amino
`acid
`con-
`plasma
`profiles
`analysis
`of vari-
`
`Results
`
`Plasma
`
`amino
`
`acid
`
`concentrations
`
`fasting
`preload,
`The
`listed
`are
`centrations
`subjects
`the
`control
`1 . Cirrhotics
`ure
`branched-chain
`leucine;
`p
`< 0.01)
`but
`(p
`0.05),
`<
`tyrosine
`(p
`
`<
`
`amino
`(basal)
`differences
`in Table
`are
`illustrated
`and
`cirrhotics
`concentrations
`exhibited
`lower
`amino
`acids
`(p
`< 0.05
`for
`isoleucine
`0. 10
`for
`valine)
`and
`taurine
`in
`plasma
`higher
`concentrations
`ofplasma
`methionine
`phenylalanine
`(p
`0.01),
`serine
`(p
`0.05),
`<
`<
`0.005),
`cyst(e)ine
`(free
`cysteine
`+ cys-
`
`plasma
`2 and
`
`con-
`acid
`between
`in Fig-
`of
`the
`and
`(p
`
`and
`
`<
`
`Eton Ex. 1040
`2 of 6
`
`(cid:18)
`(cid:17)
`

`

`IMPAIRED
`
`CYSTEINE
`
`USE
`
`BY CIRRHOTICS
`
`1403
`
`2
`TABLE
`Basal
`plasma
`
`5
`
`amino
`
`acid
`
`concentrations
`
`in control
`
`and
`
`cirrhotic
`
`Plasma
`
`am mo acid
`
`concentration
`
`Amino
`
`acid
`
`Control
`
`Cirrhotic
`
`(cid:1)mo//L
`
`0
`
`2
`
`4
`
`6
`
`8
`
`Time
`
`(hr)
`
`0E C0
`
`C4
`
`)
`
`UC0U 4
`
`)
`
`E4
`
`’
`(U
`
`0(cid:1)
`
`cysteine
`Free
`load.
`an oral L-cysteine
`after
`cyst(e)ine
`determined
`cysteine
`(0) were
`and
`protein-bound
`after
`the
`oral
`L-cysteine
`load.
`text
`at various
`times
`for
`control
`subjects
`and
`cirrhotics
`shown
`respectively.
`Total
`plasma
`cyst(e)ine
`values
`shown
`both
`groups.
`Total
`plasma
`and
`cirrhotics
`are
`significantly
`different
`val-
`
`as
`The
`in
`
`are
`((cid:1)) mean
`cyst(e)ine
`control
`
`from
`
`for
`
`Alanine
`Glutamine
`Glycine
`Isoleucine
`Leucine
`Methionine
`Phenylalanine
`Serine
`Taurine
`Threonine
`Tyrosine
`TPCII
`

`

`
`433.6±25.5
`606.
`1 ± 54.5
`± 23.8
`272.7
`77.8
`4.9
`128.8±
`15.3
`47.7
`0.35
`53.0
`6.6
`73.0
`8.4
`95.1
`17.1
`126.0±
`3.2
`0.55
`56.8
`214.8±
`13.5
`

`

`

`

`

`

`

`
`367.3±51.9
`56 1 .0 ± 29.3
`295.9
`± 20.3
`4.8t
`46.8
`13.7t
`2.8t
`12.8t
`4.3t
`9.2(cid:1)
`12.7
`6.0(cid:1)
`
`94.2±
`63.2
`89.4
`94.3
`46.1
`135.2±
`129.7

`288.9±27.l(cid:1)
`

`

`
`5i(cid:1)±SEM.
`t Significantly
`:j: Significantly
`§ Significantly
`II TPC,
`total
`cysteine).
`#{182}
`Significantly
`
`different
`different
`different
`
`from
`from
`from
`
`control
`control
`control
`
`values,
`values,
`values,
`
`p < 0.05.
`p < 0.01.
`p <
`0.005.
`
`plasma
`
`cysteine
`
`(cysteine
`
`+ cystine
`
`+
`
`protein-bound
`
`different
`
`from
`
`control
`
`values,
`
`p < 0.025.
`
`cyste-
`con-
`that
`
`Downloaded from https://academic.oup.com/ajcn/article-abstract/50/6/1401/4695064 by barrettrabinow@gmail.com on 16 May 2020
`
`+ cysteine
`tine
`p
`0.025).
`me,
`<
`comitant
`with
`
`mixed
`The
`a decrease
`
`disulfides
`in
`increase
`in plasma
`
`+ protein-bound
`plasma
`cyst(e)ine
`taurine
`suggests
`
`2. Plasma
`FIG
`(#{149}),cystine
`(A),
`described
`in the
`mean
`concentrations
`panels
`A and
`B,
`± SEM are
`also
`cystine
`values
`of
`ues(p <0.001).
`
`impaired
`
`in cirrhotic
`
`patients
`
`rel-
`
`was
`utilization
`cysteine
`subjects.
`to control
`ative
`oral
`30 mm after
`within
`Plasma
`cyst(e)ine
`increased
`1 h in
`both
`was
`maximal
`at
`cysteine
`administration
`and
`(Fig
`2);
`however,
`cirrhot-
`control
`subjects
`and
`cirrhotics
`increase
`in cyst(e)ine
`than
`ics
`exhibited
`a twofold
`greater
`first-order
`elimination
`the
`control
`subjects.
`After
`was
`significantly
`cyst(e)ine
`occurred;
`elimination
`by
`both
`the
`plasma
`in the
`cirrhotic
`group
`as
`shown
`rate
`(Table
`3).
`life
`and
`the metabolic
`clearance
`due
`The
`elevation
`in
`plasma
`cyst(e)ine
`was
`primarily
`to an
`increase
`in cystine
`2). Plasma
`cystine
`was max-
`
`4)
`-
`(U
`
`,(cid:1)
`-
`-
`(cid:1) (cid:1)
`
`4)
`=4)
`
`-
`
`(cid:1)-
`
`4)
`
`-
`.(cid:1)
`E
`
`L.
`4)
`
`.
`
`(cid:1) (cid:1) (cid:1)
`4)
`#{163} (cid:1)
`-
`5’
`
`C)
`
`I-.
`
`>
`
`Amino
`
`Acid
`
`4)
`
`(U
`
`> 4
`
`)
`
`E 0z 0
`
`FIG 1 . Percent
`from
`acids
`amino
`plasma
`basal
`ofcii-rhotic
`deviation
`subjects
`in control
`((cid:1)zmol/L)
`plasma
`values
`The mean
`control
`values.
`values
`cirrhotic
`mean
`ofthe
`were
`set at 100% and
`the percent
`deviations
`TPC is total
`and
`plasma
`cysteine
`were
`calculated
`for
`each
`amino
`acid.
`includes
`free
`cysteine,
`cysteine
`as
`cystine,
`and
`protein-bound
`cysteine.
`(see text).
`
`significant
`
`values
`
`are marked
`
`with
`
`an
`
`asterisk
`
`Statistically
`
`L-
`
`of
`
`slower
`half-
`
`1 h,
`
`(Fig
`
`3
`TABLE
`Pharmacokinetic
`oral
`bolus
`
`variables
`of L-cysteine5
`
`ofplasma
`
`cyst(e)ine
`
`elimination
`
`after
`
`an
`
`Maximal
`concentration
`
`plasma
`
`/.LFflO//L
`
`t 1/2
`
`h
`
`Control
`Cirrhotict
`
`336.0
`664.5
`
`± 37. 1
`64.
`1
`

`
`3.48
`± 0.34
`5. 18 ± 0.98
`
`Metabolic
`clearance
`
`rate
`
`L/h
`
`1 .4 1 ±0.15
`0.94
`± 0.16
`
`5i(cid:1)±SEM.
`t Significantly
`
`different
`
`from
`
`controls
`
`for
`
`all
`
`values,
`
`p <
`
`.0 1.
`
`Eton Ex. 1040
`3 of 6
`
`(cid:1)
`(cid:1)
`(cid:1)
`(cid:1)
`

`

`TRIBBLE
`
`ET AL
`
`Time
`
`(hr)
`
`1404
`
`4)
`
`34
`
`’
`.5
`
`0
`.C
`I.-
`
`cysteine
`FIG 3. Plasma
`plasma
`load. The mean
`by
`dividing
`free
`cysteine
`various
`bound
`cysteine
`at
`Control
`values,
`open
`bars;
`ues are
`significantly
`different
`
`an oral L-cysteine
`after
`status
`thiol:disulfide
`ratio was
`calculated
`cysteine
`thiol-disulfide
`as
`cystine
`and
`protein-
`the
`cysteine
`present
`± SEM.
`i
`times
`postload.
`Values
`represent
`cirrhotic
`values,
`shaded
`bars. Cirrhotic
`val-
`from control
`values
`(p < 0.005).
`
`by
`
`Downloaded from https://academic.oup.com/ajcn/article-abstract/50/6/1401/4695064 by barrettrabinow@gmail.com on 16 May 2020
`
`0-6
`
`6-12
`
`12-18
`
`18-24
`
`0-24
`
`Time
`
`(hr)
`
`FIG 4. Percent
`of sulfur
`cysteine
`load. H2S, S042
`the
`text.
`The mean
`increase
`basal
`L-cysteine
`load
`over
`the
`sponding
`time
`period
`is divided
`open
`bars;
`cirrhotic
`values,
`shaded
`cantly
`different
`from
`control
`values
`terisk.
`
`urine
`in the
`excreted
`load
`determined
`and
`taurine
`were
`(±SEM)
`in total
`S excretion
`urinary
`S excretion
`during
`by the
`total
`S load.
`Control
`are
`bars.
`Cirrhotic
`values
`< 0.05) where marked
`(p
`
`an oral
`after
`as described
`in
`after
`an oral
`the
`corre-
`values,
`signifi-
`with
`as-
`
`L-
`
`that
`reveal
`not
`shown)
`cystine,
`were
`excreted
`
`only
`the
`of
`cysteine,
`in the
`
`insignificant
`S-containing
`homocys-
`urine
`of ci-
`
`and
`7)
`(1 5-1
`viously
`data
`1%;
`(<
`amounts
`methionine,
`acids
`amino
`and
`cystathionine
`teine,
`group.]
`ther
`load was
`cysteine
`S from the
`ofthe
`percent
`Thirty-one
`the
`first
`within
`of control
`subjects
`excreted
`in the
`urine
`with
`each
`4). This
`percentage
`decreased
`6 h postload
`(Fig
`56% was
`consecutive
`6-h
`urine
`sample.
`Approximately
`A sim-
`excreted
`within
`24 h of cysteine
`administration.
`within
`group
`ilar
`amount
`was
`excreted
`by the
`cirrhotic
`but
`of S in
`the
`this
`24-h
`the
`distribution
`period
`(54%)
`was
`four
`6-h
`urine
`samples
`different.
`Corresponding
`to
`the
`slower
`rate
`of cyst(e)ine
`clearance
`from the
`less
`S was
`excreted
`in the
`urine
`within
`the
`first
`24
`h, S excretion
`was
`not
`significantly
`different
`basal
`values
`in either
`group
`although
`only
`load
`had
`been
`accounted
`for
`in the
`urine.
`et al (18)
`Krijgsheld
`ac-
`to
`inability
`reported
`a similar
`discrep-
`The
`count
`for
`all S after
`an
`oral
`cysteine
`load.
`is probably
`not
`ancy
`between
`cysteine
`intake
`and
`output
`S because
`this
`is a
`due
`to a concomitant
`increase
`in fecal
`The
`cysteine
`may
`very
`minor
`route
`of S excretion
`(19).
`the
`form
`pro-
`body
`have
`been
`retained
`in
`the
`in
`teins
`and/or
`glutathione
`(a-glutamyl-cysteinyl-glycine)
`(20,
`21).
`
`plasma,
`6 h. After
`from
`the
`of
`
`the
`
`S
`
`half
`
`of
`
`Discussion
`A recent
`rhotic
`patients
`
`strategy
`has
`
`in the
`been
`
`treatment
`the
`use
`
`of hospitalized
`tailor-made
`
`of
`
`cir-
`nutn-
`
`at
`
`to
`
`imal
`subjects
`creased
`in
`both
`values
`thiol
`cystine
`both
`time
`control
`Urinary
`fifth
`
`elevated
`remained
`1 h and
`and
`cirrhotics.
`8 h
`in
`and
`returned
`rapidly
`Because
`cysteine
`groups.
`to a greater
`extent
`than
`disulfide
`(moles
`cysteine
`and
`protein-bound
`cysteine)
`groups
`after
`the
`L-cysteine
`load
`point
`the
`ratio
`thiol
`to
`disulfide
`of
`subjects
`than
`in cirrhotics.
`sulfur-containing
`metabolites.
`days
`ofdietary
`equilibration,
`S averaged
`0.50
`g/d
`± 0.03
`g/d
`for
`and
`0.39

`0.04
`accounted
`for
`(cid:1)-85%
`the
`of
`the
`remainder
`was
`comprised
`percentages
`similar
`to
`
`(cid:1)-
`
`are
`
`to
`
`for
`Free
`preload
`increased
`did
`cystine,
`per moles
`was
`(Fig
`
`control
`h in
`‘-(cid:1)-4
`in-
`also
`cysteine
`4 h
`by
`values
`preload
`over
`ratio
`the
`cysteine
`increased
`3). At
`was
`greater
`
`of
`as
`in
`every
`in
`
`fourth
`the
`On
`excretion
`urinary
`for control
`SEM)
`(1±
`(Table
`4).
`cirrhotics
`S in
`both
`urinary
`of
`taurine.
`mostly
`those
`reported
`pre-
`
`and
`oftotal
`subjects
`S042
`groups;
`[These
`
`TABLE
`Basal
`and
`
`4
`
`post-ba
`
`d urinary
`
`su lfur
`
`excretion
`
`Control
`
`Cirrhotic
`
`Total
`S
`
`Inorganic
`S
`
`Taurine
`
`Total
`S
`
`Inorganic
`S
`
`Taurine
`
`Basal
`Postload
`
`0.50
`2.ll(cid:1)
`
`g/d
`
`0.43
`l.84(cid:1)
`
`0.07
`0.25(cid:1)
`
`0.38
`l.42(cid:1)
`
`g/d
`
`0.32
`l.37
`
`0.06
`0.07
`
`S Significantly
`
`different
`
`from
`
`basal
`
`values,
`
`p < 0.01.
`
`Eton Ex. 1040
`4 of 6
`
`

`

`IMPAIRED
`
`CYSTEINE
`
`USE
`
`BY CIRRHOTICS
`
`1405
`
`Downloaded from https://academic.oup.com/ajcn/article-abstract/50/6/1401/4695064 by barrettrabinow@gmail.com on 16 May 2020
`
`subjects
`study
`present
`which
`g) diet,
`tein
`(40
`of hepatic
`with
`a history
`higher
`concentrations
`the
`activities
`creases
`in
`ble
`for
`the
`catabolism
`Accordingly,
`the
`present
`teine
`tolerance
`in cirrhotics
`to
`be
`extended
`to
`higher
`take.
`Provision
`rhotic
`patient
`cal
`treatment
`cause
`of
`the
`that
`accompany
`thesis
`from
`of
`a source
`these
`studies
`hypercyst(e)inemia,
`unless
`the
`dosage
`
`the
`
`equilibrated
`were
`used
`in
`is often
`encephalopathy.
`intake
`of
`protein
`enzymes
`of numerous
`amino
`acids
`ofthe
`dietary
`ofimpaired
`demonstration
`on
`a low-protein
`diet
`concentrations
`protein
`
`of
`
`to a low-pro-
`cirrhotic
`patients
`Adaptation
`involves
`responsi-
`(35,
`36).
`cys-
`needs
`in-
`
`to
`in-
`
`that
`of a diet
`is a fundamental
`plan.
`This
`is often
`severe
`protein
`and
`liver
`disease.
`methionine
`may
`cysteine
`some
`indicate,
`such
`with
`ofcysteine
`
`repletion
`supports
`component
`difficult
`amino
`Impaired
`necessitate
`cirrhotic
`a supplement
`possible
`toxic
`is carefully
`
`of
`ofthe
`to achieve
`intolerances
`acid
`cysteine
`biosyn-
`the
`provision
`patients.
`Yet,
`could
`lead
`consequences
`adjusted.
`
`cir-
`the
`mcdi-
`be-
`
`of
`as
`to
`
`B
`
`to
`
`References
`
`I . Rose WC. The
`amino
`Rev
`1957;27:63l-47.
`PJ. Nutrient
`2. Rudman
`D, Williams
`Rev
`1985;43:l-14.
`teral
`nutrition.
`Nutr
`concepts
`JD.
`Newer
`3. Laidlaw
`SA, Kopple
`amino
`acids. Am J Clin Nutr
`l987;46:593-605.
`for
`al. Evidence
`et
`4. Horowitz
`JH,
`Rypins
`EB,
`Henderson
`JM,
`pairment
`of
`transsulfuration
`pathway
`in cirrhosis.
`Gastroenterol-
`ogy 1981:81:668-75.
`M, Ansley
`5. Rudman
`D, Kutner
`hypocystinemia,
`Hypotyrosinemia,
`nutrition
`parenteral
`during
`total
`ology 198 l;81:1025-35.
`6. Chawla
`RK,
`Lewis
`FW, Kutner
`man D. Plasma
`cysteine,
`cystine,
`troenterology
`1 984;
`84:770-6.
`Kang
`SS, Wang
`PWK,
`Curley
`protein-bound
`homocyst(e)ine
`1982;
`16:370-2.
`A biometric
`FG.
`8. Harris
`JA,
`Benedict
`DC: Carnegie
`man. Washington,
`Brigham
`MP,
`Stein WH,
`Moore
`and
`cystine
`in
`human
`blood
`1633-8.
`10. Malloy
`free
`15.
`1 1 . Gaitonde
`nation
`amino
`12. Hawk
`chemistry.
`Chasson
`by means
`Technol
`14. Mattson
`tions. Oak
`lob V, Coon
`
`acid
`
`requirements
`
`ofadult
`
`man.
`
`Nutr Abstr
`
`deficiencies
`
`during
`
`total
`
`paren-
`
`of
`
`the
`
`indispensable
`
`im-
`
`J, Janson
`and
`ofcirrhotic
`
`R, Chipponi
`failure
`to
`patients.
`
`J, Bain RP.
`nitrogen
`retain
`Gastroenter-
`
`MH,
`and
`
`Bate DM,
`glutathione
`
`Roy RGB,
`in cirrhosis.
`
`Rud-
`Gas-
`
`of D-penicillamine
`effect
`K. The
`in
`homocystinurics.
`Pediatr
`
`on
`Res
`
`metabolism
`ofbasal
`study
`19 19:279-89.
`Institution,
`S. The
`concentrations
`plasma.
`J Clin
`
`of
`
`cysteine
`l960;32:
`
`Invest
`
`DK,
`Rassin
`MH,
`bound
`plasma
`
`GE.
`Gaull
`cyst(e)ine.
`
`for measurement
`A method
`Anal
`Biochem
`1981;
`1 12:407-
`
`and
`
`in
`
`of
`
`method
`MK. A spectrophotometric
`of other
`cysteine
`in
`the
`presence
`of
`acids.
`Biochem
`J 1967;
`104:627-33.
`Practical
`PB, Oser
`BL, Summerson
`WH.
`1947.
`12th ed. New York:
`Blakiston,
`AL, Grady
`HJ,
`Stanley
`MA.
`Determination
`of
`automated
`chemical
`analysis.
`Tech
`196 1;30:207-
`12.
`concepts,
`DE.
`Statistics:
`difficult
`Park,
`IL: Bolchazy-Carducci
`WW,
`Sloan
`M. Altered
`
`for direct
`naturally
`
`determi-
`occurring
`
`physiological
`
`creatinine
`of
`Regist
`Med
`
`Bull
`
`understandable
`Publishers,
`clearance
`of
`
`explana-
`
`1986.
`free amino
`
`acids
`
`7.
`
`9.
`
`13.
`
`1 5.
`
`repletion
`nutritional
`and
`spe-
`of protein
`purpose
`of
`The
`of cirrhotic
`pa-
`determine
`the
`intake
`of
`
`of
`L-
`
`was
`in
`and
`
`t1/2
`in to-
`pri-
`both
`the
`state
`of cys-
`
`and
`for
`
`affect
`which
`formulations,
`tional
`consequences
`the
`minimizing
`while
`intolerances
`(22-25).
`amino
`acid
`cific
`the
`examine
`response
`study
`was
`to
`this
`thus
`ofL-cysteine,
`and
`to oral
`loads
`tients
`the
`feasibility
`of
`supplementing
`nutritional
`acid.
`these
`patients
`with
`this
`amino
`ability
`the
`in
`We
`found
`a significant
`impairment
`administered
`cirrhotic
`patients
`to
`process
`orally
`the
`elimination
`cysteine,
`as
`reflected
`in a higher
`plasma
`increase
`and
`a lower metabolic
`clearance
`rate.
`The
`load
`tal
`plasma
`cyst(e)ine
`after
`the
`L-cysteine
`cystine
`marily
`due
`to
`an
`increase
`in
`plasma
`groups.
`Impaired
`plasma
`cysteine
`elimination
`accompanying
`alteration
`in the
`cysteine
`oxidation
`could
`result
`in 1) high
`circulating
`concentrations
`teine
`in cirrhotic
`patients
`receiving
`cysteine-containing
`meals;
`tau-
`decreased
`production
`the
`amino
`acid
`of
`2)
`rime, which
`may
`critical
`function
`of nervous
`be
`the
`for
`and
`cardiac
`tissue
`(26);
`and
`3) alterations
`in the
`oxida-
`tion
`state
`of
`plasma
`protein
`sulfhydryl
`groups
`and,
`hence,
`protein
`conformation
`and
`activity
`(27).
`Consis-
`is the
`tent with
`this
`possibility
`known
`toxicity
`of excess
`dietary
`cysteine
`in
`the mammal,
`manifested
`by
`neuro-
`(28).
`logic
`hepatic
`dysfunctions
`lesions
`and
`post-
`prolonged
`The
`pathophysiological
`the
`basis
`is
`not
`cirrhotics
`load
`elevation
`of
`plasma
`in
`cysteine
`immedi-
`known.
`Decreased
`hepatic
`ofcyst(e)ine
`uptake
`Re-
`ately
`after
`absorption
`is
`explanation.
`a plausible
`perfu-
`duced
`uptake
`could
`from diminished
`portal
`result
`cys-
`sion
`and/or
`a curtailed
`ability
`ofthe
`liver
`to remove
`uptake
`t(e)ine
`from
`the
`perfusate.
`Impaired
`cyst(e)ine
`to
`de-
`from
`the
`plasma
`potentially
`could
`secondary
`be
`showed
`plasma
`glutathione.
`Beatty
`et a!
`(29,
`30)
`creased
`by
`that
`liberation
`of cysteine
`from
`cystine,
`glutathione
`potentiates
`hepatic
`cysteine
`uptake.
`By a thiol-disulfide
`interchange
`reaction
`with
`glutathione,
`one mole
`of cys-
`to
`tine
`is converted
`one mole
`of
`cysteine-glutathione-
`and
`mixed
`disulfide
`one mole
`of
`free
`cysteine.
`Although
`the
`we did
`not
`have
`resources
`to measure
`plasma
`gluta-
`thione
`in this
`study,
`Chawla
`et al (6, 3 1) reported
`subnor-
`mal
`plasma
`glutathione
`concentrations
`in
`cirrhotic
`patients
`maintained
`on
`mixed
`foods,
`enteral
`either
`mixtures,
`or parenteral
`formulas.
`Decreased
`plasma
`glu-
`tathione
`in cirrhosis
`suggests
`decreased
`hepatic
`concen-
`trations
`because
`plasma
`glutathione
`concentrations
`have
`been
`shown
`to parallel
`hepatic
`concentrations
`in experi-
`mental
`animals
`(32).
`lower
`The
`significantly
`subjects
`than
`in the
`control
`ofcysteine
`block
`in conversion
`oxidation.
`carboxylation
`and
`in
`centrated
`platelets
`and
`taurine
`plasma
`require
`which
`plasma,
`not
`was
`the
`question
`taurine
`ther
`evaluation
`before
`The
`plasma
`essential
`to increase
`with
`increasing
`
`plasma
`could
`
`cirrhotics
`in the
`taunne
`a partial
`in part
`reflect
`by hepatic
`de-
`to taurine
`however,
`is con-
`Taunne,
`measurements
`of
`precise
`of
`platelet-free
`preparation
`Consequently,
`study.
`in our
`requires
`in cirrhotics
`will
`be possible.
`concentrations
`intake
`(33,
`
`of
`
`done
`status
`conclusions
`acid
`amino
`protein
`
`fur-
`
`tend
`In the
`
`34).
`
`Eton Ex. 1040
`5 of 6
`
`

`

`Downloaded from https://academic.oup.com/ajcn/article-abstract/50/6/1401/4695064 by barrettrabinow@gmail.com on 16 May 2020
`
`1406
`
`TRIBBLE
`
`ET AL
`
`16.
`
`17.
`
`19.
`
`20.
`
`21.
`
`from plasma
`l966;6:233-9.
`Cascino
`A, Cangiano
`L. Plasma
`amino
`Dis
`l978;23:591-8.
`CampbellJA.
`JW,
`SB, Cowan
`Dabry
`ZI,
`Shadarevian
`acids
`to
`urinary
`sulphur
`amino
`of
`of
`dietary
`intake
`1965;206:931-3.
`in man. Nature
`inorganic
`sulphate
`Scholtens
`E, Mulder
`Glazenburg
`EJ,
`I 8. Krijgsheld
`KR,
`dation
`of i- and D-cysteine
`to inorganic
`sulfate
`and
`rat.
`Biochem
`Biophys
`Acta
`198
`1 ;677:7-
`I 2.
`Yamaguchi
`K, Sakakibara
`5, Asamizu
`Induction
`of
`cysteine
`oxidase
`in
`liver.
`II. The
`measurement
`rat
`metabolism
`in vivo
`and
`the activation
`ofin
`vivo activity
`oxidase.
`Biochem
`Biophys
`Acta
`l973;297:48-59.
`Tateishi
`N, Higashi
`T, Naruse
`A, Nakashima
`moto
`Y. Rat
`liver
`glutathione:
`possible
`teine.
`J Nutr
`1977;
`107:51-60.
`Sakamoto
`K,
`A, Hikito
`Tateishi
`N, Higashi
`T, Naruse
`cysteine
`of dietary
`contributions
`of
`sulfur
`atoms
`to
`rat
`liver
`glutathione
`and
`proteins.
`J Biochem
`22. Bleier
`J, Smith
`J, Heymsfield
`SB. Repletion
`rhotic
`using
`high
`caloric
`density
`enteral
`formulae
`1979;3:512 (abstr).
`
`of patients
`
`with
`
`cirrhosis
`
`of
`
`the
`
`liver.
`
`J Surg
`
`Res
`
`C, Calcaterra
`imbalance
`
`acids
`
`V. Rossi-Fanelli
`in patients
`with
`
`F, Capocaccia
`liverdisease.
`
`Dig
`
`Relationship
`excretion
`
`of
`
`GJ.
`taurine
`
`The
`
`oxi-
`in the
`
`and
`
`activation
`of
`cysteine
`of cysteine
`
`J.
`
`K, Shiozaki
`as a reservoir
`
`H, Saka-
`of cys-
`
`role
`
`Y. Relative
`and methionine
`198
`l;90:l603-lO.
`of
`the
`cachetic
`(HCDF).
`
`cir-
`JPEN
`
`23.
`
`Achord
`coholic
`24. McGhee
`effects
`thy,
`tients.
`25. Millikan
`nutrition
`Ann
`Surg
`
`role
`the
`and
`JL. Malnutrition
`Am J Gastroenterol
`liver
`disease.
`WJ,
`JM, Millikan
`A, Henderson
`modular
`and
`a casein
`of Hepatic-Aid
`acids,
`and
`nitrogen
`plasma
`amino
`197:288-94.
`Ann
`Surg
`1983;
`JM, Warren
`WJ, Henderson
`with
`F080
`in cirrhotics
`with
`1983;
`197:294-304.
`
`ofnutritional
`l987;82:l-7.
`of the
`et al. Comparison
`diet
`on encephalopa-
`balance
`in cirrhotic
`
`support
`
`in al-
`
`pa-
`
`parenteral
`et al. Total
`WD,
`subclinical
`encephalopathy.
`
`26.
`
`27.
`
`29.
`
`30.
`
`31.
`
`33.
`
`35.
`
`Sturman
`KC,
`Hayes
`1:40 1-25.
`1981;
`distinct
`RB. How many
`Freedman
`involving
`cellular
`processes
`several
`change? FEBS Lett 1979;97:20l-lO.
`28. Wellner
`D, Meister
`A. A survey
`of
`metabolism
`and
`transport
`in man.
`911-68.
`Beatty
`thesis
`Biophys
`Beatty
`status
`1227-30.
`MH,
`CJ,
`Berry
`RK,
`Chawla
`transsulfuration
`pathway
`of
`trations
`and intravenous
`hyperalimentation
`J Clin Nutr
`l985;42:577-84.
`and
`32. Kaplowitz
`N. The
`importance
`one. Yale
`J Biol Med
`198 1 ;54:497-502.
`B, Rand
`Fernstrom
`JD, Wurtman
`Ri,
`Hammarstrom-Wiklund
`WM, Munro HN, Davidson
`CS. Diurnal
`variations
`in plasma
`con-
`amino
`acids:
`centrations
`oftryptophan,
`tyrosine,
`and
`other
`neutral
`effect ofdietary
`protein
`intake.
`Am J Clin Nutr
`1979;32:1912-22.
`34. Maher
`TJ, Glaeser
`BS, Wurtman
`Ri. Diurnal
`variations
`in plasma
`red cell
`concentrations
`of
`basic
`and
`amino
`acids
`and
`in
`neutral
`and
`glutamate:
`effects
`of dietary
`pro-
`concentrations
`of aspartate
`tein
`intake.
`Am J Clin Nutr
`1984;
`39:722-9.
`RT.
`Schimke
`Adaptive
`characteristics
`ofurea
`rat.
`J Biol Chem
`l962;237:459-68.
`36. Miller
`RH,
`Eisenstein
`RS, Harper
`intake
`on branched-chain
`keto
`acid
`rat.
`J Biol Chem
`l988;263:3454-61.
`
`JA.
`
`Taurine
`
`in metabolism.
`
`Annu
`
`Rev
`
`Nutr
`
`are responsible
`enzymes
`thiol:protein-disulfide
`
`the
`for
`inter-
`
`inborn
`Annu
`
`of
`errors
`Rev
`Biochem
`
`acid
`amino
`198 1 ; 50:
`
`Involvement
`by
`isolated
`
`PW, Reed DL.
`of glutathione
`1980;204:80-7.
`Influence
`Reed DL.
`PW,
`of
`isolated
`rat hepatocytes.
`
`ofcystathionine
`rat
`hepatocytes.
`
`in the biosyn-
`Arch
`Biochem
`
`of cysteine
`Biochem
`
`the glutathione
`upon
`Pharmacol
`198 l;30:
`
`Kutner
`
`Rudman
`products
`ofmalnourished
`
`Plasma
`D.
`during
`
`concen-
`nasoenteral
`patients.
`Am
`
`regulation
`
`of hepatic
`
`glutathi-
`
`cycle
`
`enzymes
`
`in the
`
`AE. Effects
`dehydrogenase
`
`of dietary
`activity
`
`protein
`of
`the
`
`Eton Ex. 1040
`6 of 6
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket